ReviewFrontiers in cellular and infection microbiology2026
Bacterial biofilm conundrum: insight into the frontiers of antibiotic resistance and state-of-the-art anti-biofilm interventions.
Review in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Regenerative Microbiology: Harnessing Bacterial Antagonism and Spatiotemporal Signaling for Diabetic Wound Repair.Smart medicine · 2026Review
- Review
- Multidrug resistance, biofilm formation, and pathotype diversity of Escherichia coli isolated from diarrheic lambs in intensive sheep farms, Aksu, Xinjiang, China.BMC microbiology · 2026Article
- Combination-Based Biofunctional Coatings for Veterinary Biofilm-Associated Infections.Antibiotics (Basel, Switzerland) · 2026Review
- Lactic Acid Bacteria-Derived Antimicrobial and Anti-Biofilm Strategies: Mechanisms, Functional Molecules, and Emerging Biomaterial Applications.International journal of molecular sciences · 2026Review
- Burn Infections and Sepsis: Challenges and Future Prospects of Antibacterial Therapy.Antibiotics (Basel, Switzerland) · 2026Review
- Translating microbial knowledge into clinical biofilm therapies.Open medicine (Warsaw, Poland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bacterial biofilms are organized multicellular structures enmeshed in a self-secreted extracellular matrix (ECM). The communities present an alarming challenge in the fight against antimicrobial resistance (AMR). They act as a protective niche for microbes, provide chemical and physical protection to the resident cells, allow bacteria to endure host immune responses, and undermine the standard antimicrobial treatments. Despite advancements in microbiological research, biofilms remain an invisible frontier that complicates diagnostics and treatment. This perspective article provides insights into the enigmatic nature of biofilms and examines their role in human infections and diseases. It scrutinizes biofilm AMR mechanisms, including altered metabolic states, ECM-linked decreased antibiotic penetration, and augmented horizontal gene transfer. Further, it delves into the innovative anti-biofilm interventions for mitigating impact of bacterial biofilm on human health. The article also highlights the challenges in engineering ECM for eradicating the recalcitrant biofilms. The article emphasizes critical urgency to integrate biofilm-related research with the comprehensive AMR response, and advocates for interdisciplinary collaborations to transform laboratory discoveries into healthcare advancements. Research uncovering the complexity of biofilms and intriguing therapeutic approaches can address the requirement of revolutionary solutions to combat biofilm-associated infections and ensuing AMR. Overall, this perspective serves as a call to action, underscoring the compelling need to prioritize collective efforts in biofilm research to promote public health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.